西妥因1
下调和上调
气体6
衰老
血管平滑肌
钙化
内分泌学
内科学
运行x2
生物
癌症研究
化学
受体
细胞生物学
受体酪氨酸激酶
医学
转录因子
生物化学
基因
平滑肌
作者
Ileana Badi,Luigi Mancinelli,Andrea Polizzotto,Debora Ferri,Filippo Zeni,Ilaria Burba,Giuseppina Milano,Francesca Brambilla,Claudio Saccu,Marco E. Bianchi,Giulio Pompilio,Maurizio C. Capogrossi,Angela Raucci
标识
DOI:10.1161/atvbaha.118.311298
摘要
Objective— Vascular calcification (VC) is age dependent and a risk factor for cardiovascular and all-cause mortality. VC involves the senescence-induced transdifferentiation of vascular smooth muscle cells (SMCs) toward an osteochondrogenic lineage resulting in arterial wall mineralization. miR-34a increases with age in aortas and induces vascular SMC senescence through the modulation of its target SIRT1 (sirtuin 1). In this study, we aimed to investigate whether miR-34a regulates VC. Approach and Results— We found that miR-34a and Runx2 (Runt-related transcription factor 2) expression correlates in young and old mice. Mir34a +/+ and Mir34a −/− mice were treated with vitamin D, and calcium quantification revealed that Mir34a deficiency reduces soft tissue and aorta medial calcification and the upregulation of the VC Sox9 (SRY [sex-determining region Y]-box 9) and Runx2 and the senescence p16 and p21 markers. In this model, miR-34a upregulation was transient and preceded aorta mineralization. Mir34a −/− SMCs were less prone to undergo senescence and under osteogenic conditions deposited less calcium compared with Mir34a +/+ cells. Furthermore, unlike in Mir34a +/+ SMC, the known VC inhibitors SIRT1 and Axl (AXL receptor tyrosine kinase) were only partially downregulated in calcifying Mir34a −/− SMC. Strikingly, constitutive miR-34a overexpression to senescence-like levels in human aortic SMCs increased calcium deposition and enhanced Axl and SIRT1 decrease during calcification. Notably, we also showed that miR-34a directly decreased Axl expression in human aortic SMC, and restoration of its levels partially rescued miR-34a-dependent growth arrest. Conclusions— miR-34a promotes VC via vascular SMC mineralization by inhibiting cell proliferation and inducing senescence through direct Axl and SIRT1 downregulation, respectively. This miRNA could be a good therapeutic target for the treatment of VC.
科研通智能强力驱动
Strongly Powered by AbleSci AI